Fundação Butantan


Fundação Butantan is the largest producer of immunobiologicals in Latin America, dedicated to health, research, and innovation. It plays a vital role in vaccine development, production, and public health initiatives, with a mission to impact positively more lives through diversified portfolios and strategic collaborations. The organization actively participates in international meetings, such as the DCVMN, and collaborates with global health entities to increase access to vaccines and health solutions. It emphasizes governance, quality systems, and innovation, including the use of artificial intelligence to optimize processes. The foundation also engages in strategic partnerships, patent management, and continuous improvement projects, aiming to strengthen the health industrial complex in Brazil and contribute to global health efforts.

Industries

biotechnology
non-profit

Nr. of Employees

Very Large (1000+)

Fundação Butantan

São Paulo, Sao Paulo, Brazil, South America


Patents

Use of stem cells expressing mesenchymal and neuronal markers and compositions thereof to treat neurological disease

US-12239670-B2

View Details

Recombinant protein and fragments thereof, method for producing said recombinant protein, synthetic gene and use of sculptin or recombinant protein for preparing a medicament or pharmaceutical composition for the prophylaxis and/or treatment of thromboembolic diseases or as a direct and specific inhibitor of thrombin

US-12187785-B2

View Details

Stem cells expressing mesenchymal and neuronal markers, compositions thereof, and methods of preparation thereof

US-11306290-B2

View Details

Use of stem cells expressing mesenchymal and neuronal markers and compositions thereof to treat neurological disease

US-11278574-B2

View Details

Compositions comprising stem cells expressing mesenchymal and neuronal markers and uses thereof to treat neurological disease

US-11207352-B2

View Details

Hybrid peptide, set of hybrid peptides, composition, uses of the hybrid peptide, method for inducing an immune response and kits

US-11034735-B2

View Details
View All Patents

Products

Vaccines for Influenza, Dengue, and Other Diseases

Development and production of vaccines, including the first single-dose dengue vaccine in the world.

Soros and Antivenoms

Production of twelve types of antivenoms for animal venom toxins and microorganisms.

Research Publications and Patents

Contributions to scientific literature and patent filings in health and biotechnology.


Services

Vaccine and Serum Production

Production of various vaccines and sera, including those against animal venom toxins and microorganisms.

Research and Development

Research activities focused on developing new vaccines, treatments, and health solutions.

Regulatory and Quality Control

Ensuring compliance with health regulations and maintaining high standards in production.

Innovation and Partnerships

Engagement in innovative projects, patent management, and strategic partnerships to foster technological advancement.


News & Updates

Event highlighting the work of 527 firefighters in emergency and pre-hospital care.

Regulatory approval for clinical trials of a bird flu vaccine developed by Butantan.

Application submitted for the world's first single-dose dengue vaccine.

Honors awarded for contributions during the COVID-19 pandemic.

Fundação Butantan launches a new website and enhances its communication strategies.

An article discussing the importance of governance beyond trends, emphasizing risk management and long-term planning.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.